Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion type Assertion NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_head.
- NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion description "[The observed global checkpoint signaling, in contrast to only focal areas of overabundant p53 (indicative of p53 mutation) in grade II astrocytomas, are consistent with DDR activation being an early event in gliomagenesis, initially limiting cell proliferation (low Ki-67 index) and selecting for mutations of p53 and likely other genes that allow escape (higher Ki-67 index) from the checkpoint and facilitate tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_provenance.
- NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion evidence source_evidence_literature NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_provenance.
- NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion SIO_000772 20581868 NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_provenance.
- NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion wasDerivedFrom befree-20140225 NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_provenance.
- NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_assertion wasGeneratedBy ECO_0000203 NP570006.RAHXcJEGCDdp272rD9SaGPzPxO8YqeW5Tx9Qj3DC4bvZg130_provenance.